Impact of a pharmacy-led drug-interaction screening program for patients receiving triple therapy for hepatitis C virus infection and assessment of adverse effects of triple therapy use in the general population
-
- STATUS
- Not Recruiting
Summary
The primary objective of this study is to determine the number and type of drug interactions identified in patients requiring treatment with telaprevir triple-therapy and characterize physician action based upon pharmacist recommendations. The secondary o
Description
The primary objective of this study is to determine the number and type of drug interactions identified in patients requiring treatment with telaprevir triple-therapy and characterize physician action based upon pharmacist recommendations. The secondary o
Details
| Condition | Hepatitis C |
|---|---|
| Age | 100years or below |
| Clinical Study Identifier | TX2820 |
| Last Modified on | 19 February 2024 |
Similar trials to consider
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.